TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway

Biochemical and Biophysical Research Communications

Volumn 458, Issue 4, 2015, Pages 790-795

  Zhao, Q ^a   Yang, S T ^a   Wang, J J ^a,b   Zhou, J ^a   Xing, S S ^a   Shen, C C ^a   Wang, X X ^a   Yue, Y X ^a   Song, J ^a   Chen, M ^a   Wei, Y Y ^a   Zhou, Q P ^a   Dai, T ^a   Song, Y H ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

C2C12; IGF 1; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOGENIN; PROTEIN KINASE B; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CACHEXIA; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; MOLECULAR PATHOLOGY; MOUSE; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CYTOLOGY; IMMUNOLOGY; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; INSULIN-LIKE GROWTH FACTOR I; MICE; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MYOBLASTS; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925488090     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.026     Document Type: Article

References (39)

1. V. Adams, C. Doring, and G. Schuler Impact of physical exercise on alterations in the skeletal muscle in patients with chronic heart failure Front. Biosci. 13 2008 302 311
2. M. Eikermann, G. Koch, M. Gerwig, C. Ochterbeck, M. Beiderlinden, S. Koeppen, M. Neuhauser, and J. Peters Muscle force and fatigue in patients with sepsis and multiorgan failure Intens. Care Med. 32 2006 251 259
3. C.H. Lang, R.A. Frost, and T.C. Vary Regulation of muscle protein synthesis during sepsis and inflammation Am. J. Physiol. Endocrinol. Metab. 293 2007 E453 E459
4. G.S. Filippatos, S.D. Anker, and D.T. Kremastinos Pathophysiology of peripheral muscle wasting in cardiac cachexia Curr. Opin. Clin. Nutr. Metab. Care 8 2005 249 254
5. S.P. Zhao, and L.H. Zeng Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia Int. J. Cardiol. 58 1997 257 261
6. M. Di Francia, D. Barbier, J.L. Mege, and J. Orehek Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 150 1994 1453 1455
7. L. Belec, D. Meillet, G. Gresenguet, and R.K. Gherardi Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome J. Acquir Immune Defic. Syndr. Hum. Retrovirol. 8 1995 212 214
8. J. Nakashima, M. Tachibana, M. Ueno, A. Miyajima, S. Baba, and M. Murai Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer Clin. Cancer Res. 4 1998 1743 1748
9. Y. Fong, L.L. Moldawer, M. Marano, H. Wei, A. Barber, K. Manogue, K.J. Tracey, G. Kuo, D.A. Fischman, and A. Cerami et al. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins Am. J. Physiol. 256 1989 R659 R665
10. K.J. Ladner, M.A. Caligiuri, and D.C. Guttridge Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products J. Biol. Chem. 278 2003 2294 2303
11. Y.P. Li, R.J. Schwartz, I.D. Waddell, B.R. Holloway, and M.B. Reid Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappa B activation in response to tumor necrosis factor alpha FASEB J. 12 1998 871 880
12. P. Costelli, N. Carbo, L. Tessitore, G.J. Bagby, F.J. Lopez-Soriano, J.M. Argiles, and F.M. Baccino Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model J. Clin. Invest. 92 1993 2783 2789
13. S. Acharyya, and D.C. Guttridge Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome Clin. Cancer Res. 13 2007 1356 1361
14. D. Cai, J.D. Frantz, N.E. Tawa Jr., P.A. Melendez, B.C. Oh, H.G. Lidov, P.O. Hasselgren, W.R. Frontera, J. Lee, D.J. Glass, and S.E. Shoelson IKKbeta/NF-kappa B activation causes severe muscle wasting in mice Cell 119 2004 285 298
15. R.B. Hunter, and S.C. Kandarian Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy J. Clin. Invest. 114 2004 1504 1511
16. F. Mourkioti, P. Kratsios, T. Luedde, Y.H. Song, P. Delafontaine, R. Adami, V. Parente, R. Bottinelli, M. Pasparakis, and N. Rosenthal Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration J. Clin. Invest. 116 2006 2945 2954
17. C. Dogra, H. Changotra, N. Wedhas, X. Qin, J.E. Wergedal, and A. Kumar TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine FASEB J. 21 2007 1857 1869
18. D.C. Guttridge, M.W. Mayo, L.V. Madrid, C.Y. Wang, and A.S. Baldwin Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia Science 289 2000 2363 2366
19. Y.P. Li, and M.B. Reid NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 2000 R1165 R1170
20. E.R. Barton-Davis, D.I. Shoturma, A. Musaro, N. Rosenthal, and H.L. Sweeney Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function Proc. Natl. Acad. Sci. U. S. A. 95 1998 15603 15607
21. K. Wang, L. Ni, S. Wang, and C. Zheng Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-kappa B activation J. Virol. 88 2014 7941 7951
22. D. Coletti, E. Yang, G. Marazzi, and D. Sassoon TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways EMBO J. 21 2002 631 642
23. M.D. Layne, and S.R. Farmer Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts Exp. Cell. Res. 249 1999 177 187
24. C.E. Stewart, P.V. Newcomb, and J.M. Holly Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways J. Cell. Physiol. 198 2004 237 247
25. R.C. Langen, A.M. Schols, M.C. Kelders, E.F. Wouters, and Y.M. Janssen-Heininger Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB FASEB J. 15 2001 1169 1180
26. S.E. Chen, B. Jin, and Y.P. Li TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK Am. J. Physiol. Cell. Physiol. 292 2007 C1660 C1671
27. J. Zhang, W. Wu, D. Li, Y. Guo, and H. Ding Overactivation of NF-kappa B impairs insulin sensitivity and mediates palmitate-induced insulin resistance in C2C12 skeletal muscle cells Endocrine 37 2010 157 166
28. V. Jacquemin, D. Furling, A. Bigot, G.S. Butler-Browne, and V. Mouly IGF-1 induces human myotube hypertrophy by increasing cell recruitment Exp. Cell. Res. 299 2004 148 158
29. J. Fan, P.E. Molina, M.C. Gelato, and C.H. Lang Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin Endocrinology 134 1994 1685 1692
30. P. Costelli, M. Muscaritoli, M. Bossola, F. Penna, P. Reffo, A. Bonetto, S. Busquets, G. Bonelli, F.J. Lopez-Soriano, G.B. Doglietto, J.M. Argiles, F.M. Baccino, and F. Rossi Fanelli IGF-1 is downregulated in experimental cancer cachexia Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 2006 R674 R683
31. R.A. Frost, G.J. Nystrom, and C.H. Lang Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway Endocrinology 144 2003 1770 1779
32. L. Fernandez-Celemin, N. Pasko, V. Blomart, and J.P. Thissen Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha Am. J. Physiol. Endocrinol. Metab. 283 2002 E1279 E1290
33. M.A. Wingertzahn, M.M. Zdanowicz, and A.E. Slonim Insulin-like growth factor-I and high protein diet decrease calpain-mediated proteolysis in murine muscular dystrophy Proc. Soc. Exp. Biol. Med. 218 1998 244 250
34. L. Pelosi, C. Giacinti, C. Nardis, G. Borsellino, E. Rizzuto, C. Nicoletti, F. Wannenes, L. Battistini, N. Rosenthal, M. Molinaro, and A. Musaro Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines FASEB J. 21 2007 1393 1402
35. Y.H. Song, J.L. Song, P. Delafontaine, and M.P. Godard The therapeutic potential of IGF-I in skeletal muscle repair Trends Endocrinol. Metab. 24 2013 310 319
36. Y.H. Song, Y. Li, J. Du, W.E. Mitch, N. Rosenthal, and P. Delafontaine Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting J. Clin. Invest. 115 2005 451 458
37. S.R. Broussard, R.H. McCusker, J.E. Novakofski, K. Strle, W.H. Shen, R.W. Johnson, G.G. Freund, R. Dantzer, and K.W. Kelley Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts Endocrinology 144 2003 2988 2996
38. S. Pons, and I. Torres-Aleman Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B) J. Biol. Chem. 275 2000 38620 38625
39. S. Vallee, F. Fouchier, P. Bremond, C. Briand, J. Marvaldi, and S. Champion Insulin-like growth factor-1 downregulates nuclear factor kappa B activation and upregulates interleukin-8 gene expression induced by tumor necrosis factor alpha Biochem. Biophys. Res. Commun. 305 2003 831 839